1. Home
  2. FXNC vs FULC Comparison

FXNC vs FULC Comparison

Compare FXNC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

N/A

Current Price

$31.01

Market Cap

288.4M

Sector

Finance

ML Signal

N/A

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

N/A

Current Price

$3.87

Market Cap

285.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FXNC
FULC
Founded
1907
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.4M
285.4M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
FXNC
FULC
Price
$31.01
$3.87
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$16.38
AVG Volume (30 Days)
26.5K
1.6M
Earning Date
05-12-2026
04-27-2026
Dividend Yield
2.43%
N/A
EPS Growth
96.00
N/A
EPS
1.17
N/A
Revenue
$7,717,000.00
N/A
Revenue This Year
$12.21
N/A
Revenue Next Year
$2.93
N/A
P/E Ratio
$25.90
N/A
Revenue Growth
7.40
N/A
52 Week Low
$21.59
$2.83
52 Week High
$33.24
$15.74

Technical Indicators

Market Signals
Indicator
FXNC
FULC
Relative Strength Index (RSI) 51.37 52.83
Support Level $30.71 $3.44
Resistance Level $33.02 $3.96
Average True Range (ATR) 0.98 0.09
MACD -0.15 0.01
Stochastic Oscillator 38.39 72.41

Price Performance

Historical Comparison
FXNC
FULC

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: